Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)

Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)

USD $5.99

• In the wake of KING'S RANSOM, Spidey's journey takes a BIG turn. • The revelation of GIANT-SIZE AMAZING SPIDER-MAN: KING'S RANSOM was huge, but you don't understand half of what it actually means. • But you should know that the Chameleon is making his biggest play ever as THE CHAMELEON CONSPIRACY begins here! 40 PGS./Rated T+

Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)

FAQs on Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)

How much does "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" cost at Coy's Comics?

The price of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" at Coy's Comics is USD $5.99.

What brand is "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" associated with?

"Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" is associated with the Spider-Man brand.

Who is the publisher of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)"?

The publisher of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" is Marvel Comics.

What is the genre of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)"?

The genre of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" is Superheroes.

What category does "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" fall under?

"Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" falls under the category of Comics.

Who is the artist and cover artist of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)"?

The artist of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" is Marcelo Ferreira. The cover artist is Javi Garron.

Who is the writer of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)"?

The writer of "Amazing Spider-Man #67 Garron Spider-Man Villains Variant (2018)" is Nick Spencer.